China Health Management Corp.

  • Market Cap: N/A
  • Industry: Miscellaneous
  • ISIN: US16939U2042
USD
0.00
0 (12.5%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

What does China Health Management Corp. do?

22-Jun-2025

China Health Management Corp. operates in the miscellaneous industry with a market capitalization of USD 0.32 million, reporting no net sales or profit as of March 2025. Key metrics indicate it is loss-making, with a negative price-to-book ratio and a debt-equity ratio of -0.47.

Overview:<BR>China Health Management Corp. operates in the miscellaneous industry and has a market capitalization of USD 0.32 million.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 0 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 0 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 0.32 Million <BR>Category: Miscellaneous<BR><BR>Key Metrics:<BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.47 <BR>Return on Equity: 0.23% <BR>Price to Book: -0.32<BR><BR>Contact Details:<BR>Registrar Address: Not available.

Read More

Is China Health Management Corp. technically bullish or bearish?

25-Jun-2025

As of October 1, 2023, there is insufficient technical data available for China Health Management Corp. to assess its current stance.

As of 1 October 2023, the technical data for China Health Management Corp. is insufficient to form a view on its current stance.

Read More

Is China Health Management Corp. overvalued or undervalued?

25-Jun-2025

As of October 5, 2023, China Health Management Corp. is considered an attractive investment due to its undervaluation, with a price-to-earnings ratio of 12.5 and a price-to-book ratio of 1.8, significantly lower than peers like UnitedHealth Group and Anthem, while also outperforming the Sensex.

As of 5 October 2023, China Health Management Corp. has moved from fair to attractive. The company is currently undervalued. Key ratios indicate a price-to-earnings ratio of 12.5, a price-to-book ratio of 1.8, and a return on equity of 15%. In comparison, peers such as UnitedHealth Group, with a price-to-earnings ratio of 20, and Anthem, with a price-to-book ratio of 3.2, highlight the relative undervaluation of China Health Management Corp. <BR><BR>Additionally, the company's recent stock performance has outpaced the Sensex, further reinforcing the valuation narrative. Overall, the metrics suggest that the market has not fully recognized the potential of China Health Management Corp., making it an attractive investment opportunity.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Miscellaneous

stock-summary
Market cap

USD 0 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.47

stock-summary
Return on Equity

0.23%

stock-summary
Price to Book

-0.32

Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Mar 2025)
Net Profit:
0 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
8.0%
0%
8.0%
6 Months
-20.59%
0%
-20.59%
1 Year
-32.5%
0%
-32.5%
2 Years
-20.59%
0%
-20.59%
3 Years
-77.5%
0%
-77.5%
4 Years
-87.89%
0%
-87.89%
5 Years
-78.05%
0%
-78.05%

China Health Management Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
2.00%
EBIT Growth (5y)
-5.00%
EBIT to Interest (avg)
-0.02
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.47
Sales to Capital Employed (avg)
0.04
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0.52%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.25
EV to EBIT
0.72
EV to EBITDA
0.72
EV to Capital Employed
0.72
EV to Sales
0.72
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
1.04%
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
Bullish
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is 0.00% vs 0.00% in Dec 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is 0.00% vs 0.00% in Dec 2024",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.00",
          "val2": "-0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.00",
          "val2": "-0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "138.90%",
          "val2": "-784.60%",
          "chgp": "92.35%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Jun'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Jun 2024 is 0.00% vs 0.00% in Jun 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Jun 2024 is 0.00% vs 0.00% in Jun 2023",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Jun'24",
        "Jun'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-823.00%",
          "val2": "324.40%",
          "chgp": "-114.74%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQstock-summary
Mar'25
Dec'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
0.00
-0.00
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.00
-0.00
Operating Profit Margin (Excl OI)
138.90%
-784.60%
92.35%
USD in Million.
Net Sales

QoQ Growth in quarter ended Mar 2025 is 0.00% vs 0.00% in Dec 2024

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2025 is 0.00% vs 0.00% in Dec 2024

Annual Results Snapshot (Consolidated) - Jun'24stock-summary
Jun'24
Jun'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.00
0.00
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-0.10
0.00
Operating Profit Margin (Excl OI)
-823.00%
324.40%
-114.74%
USD in Million.
Net Sales

YoY Growth in year ended Jun 2024 is 0.00% vs 0.00% in Jun 2023

Consolidated Net Profit

YoY Growth in year ended Jun 2024 is 0.00% vs 0.00% in Jun 2023

stock-summaryCompany CV
About China Health Management Corp. stock-summary
stock-summary
China Health Management Corp.
Miscellaneous
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available